肌腱蛋白C(TNC)單克隆抗體
Monoclonal Antibody to Tenascin C (TNC)
TN-C; HXB; TN; GMEM; JI; Myotendinous antigen; Neuronectin; GP 150-225; Cytotactin; Hexabrachion; Glioma-associated-extracellular matrix antigen
- 編號(hào)MAB975Hu22
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(jià)(克隆號(hào))C4
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原RPB975Hu01-肌腱蛋白C(TNC)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.71mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠), Sus scrofa; Porcine (Pig，豬)
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價(jià)格¥ 634¥ 1478¥ 2112¥ 5280¥ 21120
- 欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
DAB staining on IHC-P; Samples: Human Heart Tissue; Primary Ab: 10ug/ml Mouse Anti-Human TNC Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
DAB staining on IHC-P;
Samples: Human Kidney Tissue;
Primary Ab: 10ug/ml Mouse Anti-Human TNC Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
DAB staining on IHC-P;
Samples: Human Cerebrum Tissue;
Primary Ab: 10ug/ml Mouse Anti-Human TNC Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
DAB staining on IHC-P;
Samples: Human Placenta Tissue;
Primary Ab: 10ug/ml Mouse Anti-Human TNC Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
Figure.Western Blot;Sample: Recombinant TNC, Human.
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對TNC的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別TNC。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB975Hu02 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB975Hu01 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB975Hu01 | 肌腱蛋白C(TNC)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB975Hu02 | 肌腱蛋白C(TNC)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB975Hu71 | 肌腱蛋白C(TNC)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB975Hu22 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB975Hu21 | 肌腱蛋白C(TNC)單克隆抗體 | IHC |
| MAB975Hu23 | 肌腱蛋白C(TNC)單克隆抗體 | IHC |
| MAB975Hu24 | 肌腱蛋白C(TNC)單克隆抗體 | IHC |
| SEB975Hu | 肌腱蛋白C(TNC)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB975Hu | 肌腱蛋白C(TNC)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Medical Principles and Practice | An investigation of tenascin-C levels in rheumatic mitral stenosis and their response to percutaneous mitral balloon valvuloplasty[Pubmed: 22889719] |
| Tumor Biology | Clinical significance of serum tenascin-c levels in epithelial ovarian cancer[Springer: Source] |
| Tumor Biology | Clinical significance of serum tenascin-C levels in breast cancer[Springer: Source] |
| BioFactors | Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery.[Pubmed:24823872] |
| Connective Tissue Research | Metabolic and cytoprotective effects of in vivo peri-patellar hyaluronic acid injections in cultured tenocytes[Pubmed:25333747] |
| K | Role of Tenascin-C in the differential diagnosis of small round blue cell tumors[Index.Php: Sdutfd] |
| Life Sci | A new predictor of mortality in hemodialysis patients; Tenascin-C[PubMed: 26390818] |
| Heart Research | Biomarkers Score for Patients with Mitral Stenosis: A useful conjunction with Wilkins’s Score for Early Intervention[Heartresearchopenjournal: Hroj5] |
| Ara?t?rmalar / Researches | Pankreas Adenokarsinomunda Serum Tenascin-C Düzeyi Potansiyel Bir Biyobelirte? Midir?[Cpdf:5C21620161255] |
| Archives of Dermatological Research | Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease[Pubmed:29605863] |
| Methods?in?Cell?Biology | How to detect and purify tenascin-C[Pubmed:29310788] |
| Scientific Reports | Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion[Pubmed: 31358880] |